These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 35341722)
1. Paclitaxel-Loaded TPGS Zou L; Zhang Z; Feng J; Ding W; Li Y; Liang D; Xie T; Li F; Li Y; Chen J; Yang X; Tang L; Ding W J Pharm Sci; 2022 Jun; 111(6):1776-1784. PubMed ID: 35341722 [TBL] [Abstract][Full Text] [Related]
2. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes. Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy. Zhao T; Chen H; Dong Y; Zhang J; Huang H; Zhu J; Zhang W Int J Nanomedicine; 2013; 8():1947-57. PubMed ID: 23696703 [TBL] [Abstract][Full Text] [Related]
4. Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation Ma P; Huang J; Liu J; Zhu Y; Chen J; Chen J; Lei L; Guan Z; Ban J; Lu Z J Cancer; 2023; 14(5):759-769. PubMed ID: 37056390 [No Abstract] [Full Text] [Related]
5. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study. Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment. Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586 [TBL] [Abstract][Full Text] [Related]
7. Supramolecular hydrogel based on high-solid-content mPECT nanoparticles and cyclodextrins for local and sustained drug delivery. Yin L; Xu S; Feng Z; Deng H; Zhang J; Gao H; Deng L; Tang H; Dong A Biomater Sci; 2017 Mar; 5(4):698-706. PubMed ID: 28184404 [TBL] [Abstract][Full Text] [Related]
8. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles. Calleja P; Espuelas S; Vauthier C; Ponchel G; Irache JM J Pharm Sci; 2015 Sep; 104(9):2877-86. PubMed ID: 25600579 [TBL] [Abstract][Full Text] [Related]
9. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183 [TBL] [Abstract][Full Text] [Related]
11. Preparation and anti-tumor activity of paclitaxel silk protein nanoparticles encapsulated by biofilm. Ji Y; Hao J; Tao X; Li Z; Chen L; Qu N Pharm Dev Technol; 2024 Jul; 29(6):627-638. PubMed ID: 38973737 [TBL] [Abstract][Full Text] [Related]
12. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles. Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432 [TBL] [Abstract][Full Text] [Related]
13. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid. Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer. Wang F; Li L; Liu B; Chen Z; Li C Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535 [TBL] [Abstract][Full Text] [Related]
15. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles. Wu J; Zhang J; Deng C; Meng F; Zhong Z Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid). Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829 [TBL] [Abstract][Full Text] [Related]
17. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles. Agüeros M; Zabaleta V; Espuelas S; Campanero MA; Irache JM J Control Release; 2010 Jul; 145(1):2-8. PubMed ID: 20347897 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®. Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929 [TBL] [Abstract][Full Text] [Related]
19. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery. Liu Y; Zhou C; Wang W; Yang J; Wang H; Hong W; Huang Y Mol Pharm; 2016 Dec; 13(12):4209-4221. PubMed ID: 27796093 [TBL] [Abstract][Full Text] [Related]
20. Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery. Wu T; Gong Y; Li Z; Li Y; Xiong X Curr Drug Deliv; 2021; 18(10):1505-1514. PubMed ID: 33845742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]